medigraphic.com

2006, Número 4

<< Anterior Siguiente >>

Cir Cir 2006; 74 (4)


El cáncer de cabeza y cuello. Factores de riesgo y prevención

Gallegos-Hernández JF

Idioma: Español
Referencias bibliográficas: 38
Paginas: 287-293
Archivo PDF: 90.49 Kb.


RESUMEN

La frecuencia del carcinoma epidermoide originado en mucosas de cabeza y cuello ha aumentado mundialmente en la última década, sobre todo en países con economías emergentes; el cáncer de cavidad oral ocupa el sexto lugar de todas las neoplasias. Aquí se lleva a cabo una revisión de la literatura en relación a la epidemiología y factores de riesgo en cáncer de cabeza y cuello, y se hace énfasis en la prevención del carcinoma originado en mucosas de vías aerodigestivas superiores. Se concluye que el pronóstico de los pacientes con cáncer de cabeza y cuello depende de la etapa clínica, y si bien la identificación de población en riesgo y de lesiones precursoras, así como el diagnóstico precoz disminuyen la tasa de mortalidad, el esfuerzo mayor debe hacerse en la prevención primaria.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. 1. Davidson BJ. Epidemiology and etiology. In: Shah JP, ed. Cancer of the Head and Neck. Hamilton, BC: Decker;2001. pp. 1-19.

  2. 2. Marandas P, Marandas N. Situation actuelle des cancers des vois aéro-digestives supérieures en France et données épidemiologiques. En: Marandas P, ed. Cancers des vois aéro-digestives supérieures. Données actualles. Masson. Issy-les-Moulineaux;2004. pp. 3-19.

  3. 3. Mohar A, Frías-Mendivil, Súchel-Bernal L. Epidemiología descriptiva de cáncer en el Instituto Nacional de Cancerología de México. Salud Publica Mex 1997;39:253-258.

  4. 4. Jemal A, Thomas A, Murray T, et al. Cancer Statistics 2002. CA Cancer J Clin 2002;52:6-7.

  5. 5. Shantz SP, Guo-Pei Y. Head and neck cancer incidence trends in young Americans, 1973-1997, with special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002;128:268-274.

  6. 6. Ries LAG. In: Harras A, ed. Cancer: Rates and Risks. Washington, DC: National Institutes of Health;1996. pp. 9-55.

  7. 7. International Agency for Research on Cancer Tobacco Smoking: IARC Monograph on the evaluation of the carcinogenic risk of chemicals to humans. Washington, DC: IARC;1986.

  8. 8. Rothman K, Keller A. The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. J Chronic Dis 1973;25:711-716.

  9. 9. MacFarlane GJ, Zheng T, Marshall JR, et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol 1995;31:181-187.

  10. 10. De Stefani E, Correa P, Bock FG. Comparative carcinogenic effect of two types of tobacco. Cancer 1968;21:376-389.

  11. 11. De Stefani E, Boffeta P, Oreggia F, et al. Smoking patterns and cancer of the oral cavity and pharynx: a case-control study in Uruguay. Oral Oncol 1998;34:340-346.

  12. 12. Wray A, McGuirt WF. Smokless tobacco usage associated with oral carcinoma. Arch Otolaryngol Head Neck Surg 1993;119:929-933.

  13. 13. Gritli S, Haffouz N, Attia S, et al. Les facteurs de risqué du cancer de la langue mobile chez la femme Tunisienne: etude preliminaire. Abstract 31. Congres de la Societé Francaise de carcinologie cervico-faciale. Paris;2004.

  14. 14. Maier H, Sennewald E, Séller GF, et al. Chronic alcohol consumption—the key risk factor for pharyngeal cancer. Otolaryngol Head Neck Surg 1994;110:168-173.

  15. 15. Brugere J, Guenel P, Leclerc A. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth. Cancer 1986;

  16. 57:39-45.

  17. 16. Kabat GC, Hebert JR, Wynder EL. Risk factors for oral cancer in women. Cancer Res 1989;49:2803-2806.

  18. 17. Howley PM, Ganem D, Lieff E. Etiology of cancers: viruses. DNA viruses. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice in Oncology. Philadelphia: Lippincott Williams & Wilkins;2001. pp. 158-171.

  19. 18. Steinberg BM. Viral etiology of head and neck cancer. In: Harrison LB, Sessions RB, Hong WK, eds. Head and Neck Cancer. A Multidisci-plinary Approach. Phialadelphia: Lippincott-Raven;1999. pp. 35-47.

  20. 19. Brandwein M, Zeitilin J, Nuovo GJ et al. HPV detection using “hot start” polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994;7:720-724.

  21. 20. Matthew A, Cheng JM, Sam CK, et al. A high incidence of serum IgG antibodies to the Epstein Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunol Immunother 1999;

  22. 38:68-70.

  23. 21. Zong YS, Sham JS, Ng MH, et al. Immunoglobulin A against viral capsid antigen of Epstein Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyn-geal carcinoma. Cancer 1992;69:3-7.

  24. 22. Poeschla EM, Buchschacher GL, Wong-Staal F. Etiology of cancer: viruses; RNA viruses. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer Principles & Practice in Oncology. Philadelphia: Lippincott Williams & Wilkins;2001. pp. 149-155.

  25. 23. Singh B, Balwally AN, Shaha AR, et al. Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection. Arch Otolaryngol Head Neck Surg 1996;122:639-643.

  26. 24. Sidransky D. Cancer of the head and neck. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer Principles & Practice in Oncology. Philadelphia: Lippincott Williams & Wilkins;2001. pp. 789-795.

  27. 25. Slaughter DL, Southwick HW, Smejkal W, et al. “Field cancerization” in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila) 1953;6:963.

  28. 26. Nees M, Homan N, Disher H, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res 1993;53:4189-4196.

  29. 27. Sturgis EM, Wei Q, Spitz M. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 2004;31:726-

  30. 28. Notani PN, Jayant K. Role of diet in upper aerodigestive tract cancers. Nutr Cancer 1987;10:103-113.

  31. 29. Zhang ZF, Morgenstern H, Spitz MR, et al. Marijuana use and increased risk of sequamous cell carcinoma of the hed and neck. Cancer Epidemiol Biomark Prev 1999;8:1071-1078.

  32. 30. Warnakulasuriya S. Global trends in the epidemiology of oral cancer: the current position. Oral Oncol 2005;1:27(abstr K-1).

  33. 31. Maluf FC, Sherman E, Pfister DG. Chemotherapy and chemo-

  34. prevention in head and neck cancer. In: Shah JP, ed. Cancer of the Head and Neck. Hamilton, BC: Decker;2001. pp. 444-466.

  35. 32. Petersen PE. Strengthening prevention of oral cancer¾the WHO approach. Oral Oncol 2005;1:27(abstr K-3).

  36. 33. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1993;328:15-20.

  37. 34. Papadimitrakopoulou VA, Hong WK, Lee JS, et al. Low dose isotretionin vs ß-carotene to prevent oral carcinogeneisis: long term follow-up. J Natl Cancer Inst 1997;89:257-258.

  38. 35. van Zandwijk N, Dalesio O, Pastorino U, et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J Natl Cancer Inst 2000;92:977-986.




2020     |     www.medigraphic.com